$CYTK·4

CYTOKINETICS INC · Mar 13, 2:43 PM ET

CYTOKINETICS INC 4

4 · CYTOKINETICS INC · Filed Mar 13, 2015

Insider Transaction Report

Form 4
Period: 2015-03-11
WOLFF ANDREW A
SVP Clinical R&D, CMO
Transactions
  • Sale

    Common Stock

    2015-03-11$7.80/sh19,390$151,24223,646 total
  • Sale

    Common Stock

    2015-03-11$7.80/sh1,345$10,49121,261 total
  • Exercise/Conversion

    Common Stock

    2015-03-11$6.30/sh+2,485$15,65623,746 total
  • Sale

    Common Stock

    2015-03-11$7.83/sh100$78323,646 total
  • Exercise/Conversion

    Common Stock

    2015-03-11$6.30/sh+19,390$122,15743,036 total
  • Sale

    Common Stock

    2015-03-11$7.81/sh1,040$8,12222,606 total
  • Exercise/Conversion

    Incentive Stock Option (right to buy)

    2015-03-112,4857,292 total
    Exercise: $6.30From: 2012-04-05Exp: 2022-03-05Common Stock (2,485 underlying)
  • Exercise/Conversion

    Non-Qualified Stock Option (right to buy)

    2015-03-1119,3900 total
    Exercise: $6.30From: 2012-04-05Exp: 2022-03-05Common Stock (19,390 underlying)

Documents

1 file
  • 4
    edgardoc.xmlPrimary

    PRIMARY DOCUMENT